Skip Navigation LinksHome > November 2011 - Volume 19 - Issue 6 > Congestive Heart Failure Exacerbation Secondary to Itraconaz...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e3182156810
Case Reports

Congestive Heart Failure Exacerbation Secondary to Itraconazole Therapy

Liedtke, Michelle D. PharmD; Vandaveer, Julie K. PharmD; Greenfield, Ronald A. MD; Lockhart, Staci M. PharmD

Collapse Box


Itraconazole is a commonly prescribed antifungal agent that has been associated with the occurrence of congestive heart failure (CHF) symptoms. There is currently a black box warning related to itraconazole stating that its use is contraindicated for the treatment of onychomycosis in patients with left ventricular dysfunction or a history of CHF. We report a case of a man presenting with 3 exacerbations of CHF secondary to itraconazole therapy for disseminated histoplasmosis. He was successfully treated with posaconazole with no recurrence of symptoms.

© 2011 Lippincott Williams & Wilkins, Inc.

Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.